JAZZ Insider Trading

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $9,992,963.00
Insider Selling (Last 12 Months): $27,818,364.65

Jazz Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Jazz Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jazz Pharmaceuticals Share Price & Price History

Current Price: $167.15
Price Change: Price Decrease of -3.85 (-2.25%)
As of 01/23/2026 01:47 PM ET

This chart shows the closing price history over time for JAZZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Jazz Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2025Mary Elizabeth HendersonSVPSell2,238$169.51$379,363.3819,508View SEC Filing Icon  
12/5/2025Patricia CarrCAOSell4,660$171.20$797,792.007,012View SEC Filing Icon  
11/26/2025Bruce C. CozaddDirectorSell77,500$177.81$13,780,275.00393,332View SEC Filing Icon  
11/20/2025Heather Ann McSharryDirectorSell3,415$177.78$607,118.7020,449View SEC Filing Icon  
11/18/2025Bruce C. CozaddDirectorSell18,000$181.09$3,259,620.00390,826View SEC Filing Icon  
11/18/2025Patricia CarrCAOSell5,319$182.06$968,377.147,012View SEC Filing Icon  
11/18/2025Rick E. WinninghamDirectorSell5,500$180.86$994,730.008,893View SEC Filing Icon  
11/17/2025Robert IannoneEVPSell7,159$168.26$1,204,573.3472,628View SEC Filing Icon  
10/3/2025Bruce C. CozaddDirectorSell3,500$140.00$490,000.00408,826View SEC Filing Icon  
10/1/2025Bruce C. CozaddDirectorSell2,000$131.78$263,560.00412,326View SEC Filing Icon  
9/2/2025Bruce C. CozaddDirectorSell6,000$128.62$771,720.00429,973View SEC Filing Icon  
7/1/2025Bruce C. CozaddCEOSell1,000$107.63$107,630.00436,973View SEC Filing Icon  
6/2/2025Bruce C. CozaddCEOSell500$107.90$53,950.00438,473View SEC Filing Icon  
5/12/2025Seamus MulliganDirectorBuy1,621$103.00$166,963.00101,621View SEC Filing Icon  
5/9/2025Seamus MulliganDirectorBuy100,000$98.26$9,826,000.00100,000View SEC Filing Icon  
5/1/2025Bruce C. CozaddCEOSell1,000$116.35$116,350.00439,307View SEC Filing Icon  
4/1/2025Bruce C. CozaddCEOSell1,500$123.75$185,625.00440,307View SEC Filing Icon  
3/10/2025Patricia CarrCAOSell1,140$137.81$157,103.407,012View SEC Filing Icon  
3/10/2025Robert IannoneCMOSell2,403$138.41$332,599.2379,621View SEC Filing Icon  
3/7/2025Robert IannoneCMOSell7,080$138.60$981,288.0082,024View SEC Filing Icon  
3/3/2025Bruce C. CozaddCEOSell6,500$144.25$937,625.00464,058View SEC Filing Icon  
2/27/2025Neena M. PatilEVPSell3,800$144.87$550,506.0033,318View SEC Filing Icon  
2/27/2025Patricia CarrCAOSell4,813$144.42$695,093.468,237View SEC Filing Icon  
2/3/2025Bruce C. CozaddCEOSell1,500$122.31$183,465.00439,744View SEC Filing Icon  
1/2/2025Bruce C. CozaddCEOSell1,500$123.43$185,145.00425,525View SEC Filing Icon  
12/2/2024Bruce C. CozaddCEOSell2,000$121.17$242,340.00427,025View SEC Filing Icon  
12/2/2024Patricia CarrCAOSell53$122.49$6,491.976,596View SEC Filing Icon  
11/8/2024Neena M. PatilEVPSell3,700$123.41$456,617.0033,048View SEC Filing Icon  
11/1/2024Bruce C. CozaddCEOSell1,000$110.84$110,840.00428,976View SEC Filing Icon  
9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.0014,531View SEC Filing Icon  
6/7/2024Patricia CarrCAOSell163$108.83$17,739.296,596View SEC Filing Icon  
5/3/2024Neena M. PatilEVPSell5,000$109.65$548,250.0036,629View SEC Filing Icon  
3/6/2024Patricia CarrCAOSell1,936$119.64$231,623.048,364View SEC Filing Icon  
3/1/2024Philip L. JohnsonCFOBuy12,000$119.65$1,435,800.0027,932View SEC Filing Icon  
12/4/2023Mark Douglas SmithDirectorSell417$119.27$49,735.596,888View SEC Filing Icon  
9/1/2023Neena M. PatilEVPSell1,500$144.25$216,375.0029,186View SEC Filing Icon  
8/29/2023Patricia CarrCAOSell142$143.47$20,372.745,986View SEC Filing Icon  
8/15/2023Neena M. PatilEVPSell750$139.59$104,692.5030,686View SEC Filing Icon  
8/14/2023Patricia CarrCAOSell158$138.16$21,829.286,128View SEC Filing Icon  
8/14/2023Rick E. WinninghamDirectorSell1,241$138.16$171,456.5610,444View SEC Filing Icon  
6/7/2023Patricia CarrCAOSell126$127.92$16,117.926,286View SEC Filing Icon  
6/1/2023Neena M. PatilEVPSell1,600$127.98$204,768.0032,826View SEC Filing Icon  
5/18/2023Renée D. GaláCFOSell6,000$131.75$790,500.0035,978View SEC Filing Icon  
3/15/2023Patricia CarrCAOSell1,023$133.22$136,284.066,286View SEC Filing Icon  
3/8/2023Kim SablichEVPSell3,013$139.74$421,036.6230,560View SEC Filing Icon  
3/7/2023Kenneth W. O'KeefeDirectorSell2,690$138.39$372,269.1022,889View SEC Filing Icon  
3/6/2023Finbar LarkinSVPSell1,706$143.92$245,527.5223,854View SEC Filing Icon  
3/5/2023Patricia CarrCAOSell1,148$140.76$161,592.487,309View SEC Filing Icon  
2/1/2023Bruce C. CozaddCEOSell1,000$155.79$155,790.00367,078View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JAZZ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jazz Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/23/2026Sumitomo Mitsui Trust Group Inc.3,600$0.61M0.0%N/A0.006%Search for SEC Filing on Google Icon
1/23/2026Robeco Institutional Asset Management B.V.93,649$15.92M0.0%-2.9%0.154%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management21,614$3.67M0.1%+5.6%0.036%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA8,565$1.46M0.0%-3.2%0.014%Search for SEC Filing on Google Icon
1/22/2026Westbourne Investments Inc.1,400$0.24M0.1%N/A0.002%Search for SEC Filing on Google Icon
1/21/2026Prime Capital Investment Advisors LLC3,014$0.51M0.0%+17.8%0.005%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC12,813$2.15M0.0%+1.7%0.021%Search for SEC Filing on Google Icon
1/21/2026Aaron Wealth Advisors LLC2,979$0.51M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/21/2026Rathbones Group PLC1,349$0.23M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/21/2026Capricorn Fund Managers Ltd10,000$1.70M0.4%N/A0.016%Search for SEC Filing on Google Icon
1/20/2026Perpetual Ltd154,650$26.29M0.4%-74.3%0.255%Search for SEC Filing on Google Icon
1/20/2026Philip James Wealth Mangement LLC15,936$2.71M0.3%-0.6%0.026%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc60,337$10.26M0.0%-7.8%0.099%Search for SEC Filing on Google Icon
1/16/2026Kendall Capital Management8,304$1.41M0.3%-1.8%0.014%Search for SEC Filing on Google Icon
1/16/2026Blue Trust Inc.2,993$0.51M0.0%-8.2%0.005%Search for SEC Filing on Google Icon
1/16/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management4,532$0.77M0.0%+89.3%0.007%Search for SEC Filing on Google Icon
1/15/2026BTC Capital Management Inc.47,548$8.09M0.6%-8.1%0.078%Search for SEC Filing on Google Icon
1/15/2026Range Financial Group LLC7,772$1.32M0.5%-3.8%0.013%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC15,268$2.64M0.0%+10.6%0.025%Search for SEC Filing on Google Icon
1/15/2026Retirement Systems of Alabama167,698$28.51M0.1%-11.0%0.276%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.47,535$8.08M0.3%+25.5%0.078%Search for SEC Filing on Google Icon
1/14/2026Thompson Investment Management Inc.5,765$0.98M0.1%-12.3%0.009%Search for SEC Filing on Google Icon
1/14/2026Wedge Capital Management L L P NC188,878$32.11M0.6%-10.6%0.311%Search for SEC Filing on Google Icon
1/14/2026Exchange Traded Concepts LLC1,133$0.19M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/13/2026Fort Washington Investment Advisors Inc. OH1,200$0.20M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC136,024$23.12M0.0%+2,969.1%0.224%Search for SEC Filing on Google Icon
1/8/2026Sound View Wealth Advisors Group LLC8,796$1.50M0.1%-5.4%0.014%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC9,357$1.56M0.0%+51.5%0.015%Search for SEC Filing on Google Icon
1/7/2026MassMutual Private Wealth & Trust FSB353$60K0.0%-95.2%0.001%Search for SEC Filing on Google Icon
1/7/2026CWA Asset Management Group LLC20,742$3.53M0.1%-4.8%0.034%Search for SEC Filing on Google Icon
1/7/2026Hilltop National Bank210$36K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/7/2026Sagespring Wealth Partners LLC1,411$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/5/2026Park Avenue Securities LLC6,081$1.03M0.0%+5.6%0.010%Search for SEC Filing on Google Icon
1/5/2026GoalVest Advisory LLC300$51K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC1,012$0.17M0.0%+54.5%0.002%Search for SEC Filing on Google Icon
12/15/2025Mirabella Financial Services LLP1,848$0.24M0.0%N/A0.003%Search for SEC Filing on Google Icon
12/2/2025Swiss Life Asset Management Ltd2,692$0.36M0.0%N/A0.004%Search for SEC Filing on Google Icon
12/2/2025Goldentree Asset Management LP1,137,106$149.60M12.4%N/A1.871%Search for SEC Filing on Google Icon
12/1/2025Groupama Asset Managment2,576$0.34M0.0%-70.5%0.004%Search for SEC Filing on Google Icon
12/1/2025Cambria Investment Management L.P.5,889$0.78M0.0%+7.1%0.010%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.2,068$0.27M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/19/2025Faithward Advisors LLC27,904$3.68M0.5%+93.4%0.046%Search for SEC Filing on Google Icon
11/19/2025Sunbelt Securities Inc.400$53K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/19/2025Coldstream Capital Management Inc.4,472$0.59M0.0%+36.5%0.007%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S300$40K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd356$47K0.0%+1,383.3%0.001%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC900$0.12M0.0%-6.9%0.001%Search for SEC Filing on Google Icon
11/17/2025Krensavage Asset Management LLC167,816$22.12M9.4%+1.8%0.276%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co35,106$4.53M0.0%+0.5%0.058%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP264,968$34.92M0.2%+710.7%0.436%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP11,540$1.52M0.0%-54.7%0.019%Search for SEC Filing on Google Icon
11/17/2025Alyeska Investment Group L.P.205,954$27.15M0.1%+1.0%0.339%Search for SEC Filing on Google Icon
11/17/2025Utah Retirement Systems3,100$0.41M0.0%-68.4%0.005%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC27,299$3.60M0.0%-16.5%0.045%Search for SEC Filing on Google Icon
11/17/2025Vestal Point Capital LP500,000$65.90M3.0%-58.3%0.823%Search for SEC Filing on Google Icon
11/17/2025Quantessence Capital LLC1,609$0.21M0.1%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Quarry LP2,125$0.28M0.1%-41.0%0.003%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd56,244$7.41M0.0%-54.4%0.093%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio19,144$2.52M0.0%-3.1%0.032%Search for SEC Filing on Google Icon
11/17/2025Nomura Holdings Inc.14,376$1.90M0.0%-21.7%0.024%Search for SEC Filing on Google Icon
11/17/2025Northwestern Mutual Wealth Management Co.3,331$0.44M0.0%+20.0%0.005%Search for SEC Filing on Google Icon
11/17/2025Northern Trust Corp503,550$66.37M0.0%0.0%0.829%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC20,275$2.67M0.0%+8.5%0.033%Search for SEC Filing on Google Icon
11/17/2025Measured Wealth Private Client Group LLC4,648$0.61M0.2%-4.3%0.008%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV2,480$0.33M0.0%-18.5%0.004%Search for SEC Filing on Google Icon
11/17/2025National Bank of Canada FI715$94K0.0%+66.7%0.001%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC269,107$35.47M0.0%-60.8%0.443%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.31,689$4.18M0.0%-38.0%0.052%Search for SEC Filing on Google Icon
11/17/2025Iron Triangle Partners LP150,000$19.77M2.8%N/A0.247%Search for SEC Filing on Google Icon
11/17/2025Holocene Advisors LP605,109$79.75M0.2%+28.8%0.996%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC51,192$6.75M0.0%-25.2%0.084%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC2,193$0.29M0.0%-2.8%0.004%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth4,543$0.60M0.0%-15.2%0.007%Search for SEC Filing on Google Icon
11/17/2025Distillate Capital Partners LLC111,383$14.68M0.8%+3.3%0.183%Search for SEC Filing on Google Icon
11/17/2025CSM Advisors LLC6,046$0.80M0.0%+18.6%0.010%Search for SEC Filing on Google Icon
11/17/2025California Public Employees Retirement System194,807$25.68M0.0%-14.7%0.321%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE967,901$127.57M0.0%-8.0%1.593%Search for SEC Filing on Google Icon
11/17/2025Aristotle Capital Management LLC158,056$20.83M0.0%-4.5%0.260%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.127,248$16.77M0.0%-11.8%0.209%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.1,847,455$243.50M0.1%-1.1%3.040%Search for SEC Filing on Google Icon
11/14/2025Creative Planning3,666$0.48M0.0%+36.4%0.006%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC436,443$57.52M0.3%+592.1%0.718%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC13,642$1.80M0.0%-100.0%0.022%Search for SEC Filing on Google Icon
11/14/2025AQR Capital Management LLC698,941$90.96M0.1%-12.1%1.150%Search for SEC Filing on Google Icon
11/14/2025SummitTX Capital L.P.23,005$3.03M0.1%-28.4%0.038%Search for SEC Filing on Google Icon
11/14/2025AQR Arbitrage LLC33,322$4.34M0.1%-58.9%0.055%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.158,866$20.94M0.0%-0.1%0.261%Search for SEC Filing on Google Icon
11/14/2025Man Group plc43,166$5.69M0.0%+199.4%0.071%Search for SEC Filing on Google Icon
11/14/2025Hotchkis & Wiley Capital Management LLC138,109$18.20M0.1%+364.1%0.227%Search for SEC Filing on Google Icon
11/14/2025Occudo Quantitative Strategies LP4,892$0.65M0.1%-18.8%0.008%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System55,214$7.28M0.0%+1.5%0.091%Search for SEC Filing on Google Icon
11/14/2025Logan Capital Management Inc.2,568$0.34M0.0%+134.7%0.004%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC2,500$0.33M0.0%-9.1%0.004%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 31,570$4.16M0.0%-59.5%0.052%Search for SEC Filing on Google Icon
11/14/2025Acuta Capital Partners LLC25,114$3.31M3.4%-4.4%0.041%Search for SEC Filing on Google Icon
11/14/2025Balyasny Asset Management L.P.433,139$57.09M0.1%+29.2%0.713%Search for SEC Filing on Google Icon
11/14/2025Fiduciary Trust Co12,414$1.64M0.0%-8.1%0.020%Search for SEC Filing on Google Icon
11/14/2025Shay Capital LLC15,000$1.98M0.2%N/A0.025%Search for SEC Filing on Google Icon
11/14/2025Brooklyn Investment Group1,950$0.26M0.0%+144.7%0.003%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC169,687$22.37M0.0%-38.1%0.279%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jazz Pharmaceuticals logo
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.
Read More on Jazz Pharmaceuticals

Today's Range

Now: $167.15
Low: $168.40
High: $171.51

50 Day Range

MA: $169.59
Low: $141.07
High: $180.90

52 Week Range

Now: $167.15
Low: $95.49
High: $182.99

Volume

201,120 shs

Average Volume

1,282,417 shs

Market Capitalization

$10.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top insider shareholders include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Philip L Johnson (CFO)
  8. Heather Ann Mcsharry (Director)
  9. Mary Elizabeth Henderson (SVP)
  10. Rick E Winningham (Director)
  11. Patricia Carr (CAO)
Learn More about top insider investors at Jazz Pharmaceuticals.

Who are the major institutional investors of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top institutional investors include:
  1. Wedge Capital Management L L P NC — 0.31%
  2. Retirement Systems of Alabama — 0.28%
  3. Perpetual Ltd — 0.25%
  4. SG Americas Securities LLC — 0.22%
  5. Aberdeen Group plc — 0.10%
  6. BTC Capital Management Inc. — 0.08%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.

Which major investors are selling Jazz Pharmaceuticals stock?

Within the previous quarter, JAZZ stock was sold by these institutional investors:
  1. Perpetual Ltd
  2. Wedge Capital Management L L P NC
  3. Retirement Systems of Alabama
  4. MassMutual Private Wealth & Trust FSB
  5. Aberdeen Group plc
  6. BTC Capital Management Inc.
  7. CWA Asset Management Group LLC
  8. Thompson Investment Management Inc.
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Philip L Johnson (CFO)
  8. Heather Ann Mcsharry (Director)
  9. Mary Elizabeth Henderson (SVP)
Learn More investors selling Jazz Pharmaceuticals stock.

Which major investors are buying Jazz Pharmaceuticals stock?

During the last quarter, JAZZ stock was acquired by institutional investors including:
  1. SG Americas Securities LLC
  2. Capricorn Fund Managers Ltd
  3. Hennion & Walsh Asset Management Inc.
  4. Wealth Enhancement Advisory Services LLC
  5. Aaron Wealth Advisors LLC
  6. Empirical Financial Services LLC d.b.a. Empirical Wealth Management
  7. Allspring Global Investments Holdings LLC
  8. Sagespring Wealth Partners LLC
During the last year, these company insiders have bought Jazz Pharmaceuticals stock:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
Learn More investors buying Jazz Pharmaceuticals stock.